| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. (MCRB) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. MCRB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 56.3K | $371.3K | - | |
| Other | 22.5K | $148.5K | - | |
| Dir | 11.5K | $75.7K | - | |
| Dir | 11.0K | $72.6K | - | |
| Dir | 10.0K | $66.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 25, 2016 | Afeyan Noubar74 | Director, 10% Owner | Sell | 1,000,000 | $27.60 | $27,600,000.00 | -17.7% | |
| May 24, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 9,801 | $30.00 | $294,030.00 | -5.1% | |
| May 6, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 8,507 | $24.31 | $206,802.52 | -15.7% | |
| May 5, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 59,325 | $26.13 | $1,550,277.92 | -39.5% | |
| May 3, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 67,367 | $28.70 | $1,933,196.89 | -34.2% | |
| Apr 25, 2016 | Aunins John G. | Chief Technology Officer &EVP | Sell | 18,640 | $31.94 | $595,361.60 | -25.0% | |
| Apr 7, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 9,212 | $30.00 | $276,360.00 | -28.8% | |
| Apr 7, 2016 | Cook David N | Chief Scientific Officer &EVP | Sell | 8,000 | $31.00 | $248,000.00 | -4.7% | |
| Apr 4, 2016 | Shaff Eric D.66 | CFO And EVP | Sale+OE | 6,568 | $28.85 | $189,486.80 | -100% | |
| Apr 4, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 135,788 | $27.20 | $3,693,795.49 | -34.3% |